Lightpoint Medical, an innovative medical device company specializing in imaging technologies, announced today that it has received a 2.4M Euro grant from the European Commission as part of the Horizon 2020 European Union Framework Programme for Research and Innovation, enabling the company to carry out a large-scale clinical trial in breast cancer.
The study aims to cut the rate of re-operations in breast cancer, potentially preventing many thousands of women globally from facing additional surgery, and providing significant cost savings to national healthcare systems.